Cardiometabolic Risk Clinical Trial
— CALIBEROfficial title:
CALIBER (Carbohydrates, Lipids and Biomarkers of Traditional and Emerging Cardiometabolic Risk Factors) Phase 1: A Pilot Study in Normal-weight and Overweight Adults.
Verified date | March 2018 |
Source | Liverpool John Moores University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pilot study to compare the impact of following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population.
Status | Completed |
Enrollment | 15 |
Est. completion date | December 8, 2017 |
Est. primary completion date | December 8, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 64 Years |
Eligibility |
Inclusion Criteria cohort 1: 1. BMI 18.5 - 29.9kg/m2 2. Aged 19 - 64 3. White-Caucasian 4. Score of =4 from a combination of risk markers, including - Fasting glucose concentration >5.5mmol/L = 3 points - Waist >102cm or 40 inches = 2 points (males) - Waist >94 cm or 37 inches = 1 point (males) - Waist >88cm or 34inches = 2 points (females) - Waist >80 cm or 31 inches = 1 point (females) - Systolic blood pressure>130mmHg = 1 point - Diastolic BP >85mmHg = 1 point - HDL cholesterol concentration <1.0mmol/L = 2 points - Serum triglyceride concentration >1.3mmol/L = 1 point. Exclusion Criteria cohort 1: 1. Smoker 2. Vegetarian or vegan 3. Suffering from food allergies or intolerances 4. Drinking alcohol above recommended UK government guidelines 5. Previous diagnosis of CM disease 6. Taking lipid-lowering medication 7. Taking blood pressure-lowering medication 8. Taking blood glucose-lowering medication 9. Taking dietary supplements 10. Suffering from an eating disorder 11. Current or previous renal impairment Inclusion Criteria cohort 2: 1. BMI 18.5 - 29.9kg/m2 2. Aged 19 - 64 3. White-Caucasian Exclusion Criteria cohort 2: 1. Smoker 2. Vegetarian or vegan 3. Suffering from food allergies or intolerances 4. Drinking alcohol above recommended UK government guidelines 5. Previous diagnosis of CM disease 6. Taking lipid-lowering medication 7. Taking blood pressure-lowering medication 8. Taking blood glucose-lowering medication 9. Taking dietary supplements 10. Suffering from an eating disorder 11. Current or previous renal impairment |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Liverpool John Moores University | Liverpool | Merseyside |
Lead Sponsor | Collaborator |
---|---|
Liverpool John Moores University | Liverpool Hope University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum lipid profile | Total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, small-dense LDL-C and triglycerides measured in mmol/L | 8 weeks | |
Primary | Blood glucose | Measured in mmol/L | 8 weeks | |
Primary | Systolic and diastolic blood pressure | Measured in mmHg | 8 weeks | |
Primary | Inflammatory markers, such as CRP | Measured in mg/L | 8 weeks | |
Primary | Adiponectin | Measured in µg/mL | 8 weeks | |
Primary | Fibroblast growth factor 21 (FGF21). | Measured in pg/mL | 8 weeks | |
Primary | Tumor necrosis factor alpha and Interleukin 6 | Measured in µg/mL | 8 weeks | |
Primary | Body composition - Bioelectrical impedance | Lean mass, fat mass and adipose tissue location and distribution | 8 weeks | |
Primary | Body composition - Anthropometrics | Waist, hip, neck, thigh and calf circumference measured in cm | 8 weeks | |
Secondary | Clinical traditional and emerging markers of dietary intake | Fibroblast growth factor 21 and serum metabolites | 8 weeks | |
Secondary | Food cravings | Measured via self-reported questionnaire | 8 weeks | |
Secondary | Satiety | Assessed via serum leptin levels (ng/mL) | 8 weeks | |
Secondary | Cognition | Assessed via self-reported questionnaire | 8 weeks | |
Secondary | Impact on physical activity patterns | Assessed via accelerometry | 8 weeks | |
Secondary | Adherence to assigned diet | Measured via 4-day food diaries | 8 weeks | |
Secondary | Adherence to dietary guidelines | Measured via diet quality score assessment | 8 weeks | |
Secondary | Adherence to low-carbohydrate diet | Measured via blood ketones (mmol/L) | 8 weeks | |
Secondary | Adherence to fibre recommendations | Measured via structured questionnaires | 8 weeks | |
Secondary | Adherence to taking dietary supplement for low-carbohydrate, high-fat group | Measured via counting of number of multi-vitamin and mineral supplements consumed | 8 weeks | |
Secondary | Experience with either low-carbohydrate, high-fat or high-carbohydrate, moderate-fat diet | Assessed via semi-structured interview | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02599272 -
Effects of Mixed Spices on Cardiometabolic Function - the PolySPice (PSP) Study
|
N/A | |
Completed |
NCT03731013 -
Combining a Mediterranean Diet With Physical Activity to Address Cardiometabolic Risk
|
N/A | |
Completed |
NCT03839212 -
The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men
|
N/A | |
Completed |
NCT03773900 -
Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers
|
N/A | |
Completed |
NCT05771571 -
Investigation of the Acute Effect of Novel Olive Oil on Postprandial Oxidative Stress Biomarkers (BioliveCT)
|
N/A | |
Active, not recruiting |
NCT04902417 -
Dairy and Inflammation Study
|
N/A | |
Completed |
NCT02099032 -
Milk Polar Lipids Consumption, Lipid Metabolism, and Inflammation in Menopausal Women
|
N/A | |
Completed |
NCT01467544 -
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
|
N/A | |
Completed |
NCT04011995 -
Effects of Intermittent Caloric Restriction in Youth With Cardiometabolic Risk
|
N/A | |
Completed |
NCT04190706 -
Synergistic Innovative Functional Food Concepts to Neutralize Inflammation for Cardiometabolic Risk Prevention
|
N/A | |
Completed |
NCT03274739 -
Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood
|
||
Recruiting |
NCT05400005 -
Impact of Different Types of Higher Dietary Protein Intake on Sleep Quality in Singapore Older Adults
|
N/A | |
Terminated |
NCT04737044 -
Effects of Antioxidant Sugar vs Granulated Sugar on Metabolic Outcomes in Healthy and Cardio Metabolic Subjects
|
N/A | |
Completed |
NCT05228925 -
GraviD-child Follow-up of the Children´s Health, Growth and Development Within the GraviD-study
|
||
Completed |
NCT04275440 -
Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora
|
N/A | |
Withdrawn |
NCT04359433 -
Intermittent Exercise Among Students
|
N/A | |
Completed |
NCT02146339 -
Impact of Milk Polar Lipids on Lipids Digestion, Absorption and Metabolism
|
N/A | |
Recruiting |
NCT04834687 -
Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora
|
N/A |